{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T19:36:00Z","timestamp":1761766560907,"version":"3.37.3"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:00:00Z","timestamp":1563580800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T00:00:00Z","timestamp":1563580800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12887-019-1617-1","type":"journal-article","created":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T10:02:49Z","timestamp":1563616969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["A case report of mevalonate kinase deficiency in a 14-month-old female with fevers and lower extremity weakness"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-8128","authenticated-orcid":false,"given":"Tiziana","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradford","family":"Becken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Van Mater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Theresa","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela Maradiaga","family":"Panayotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,20]]},"reference":[{"issue":"2","key":"1617_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11926-010-0086-1","volume":"12","author":"JC van der Hilst","year":"2010","unstructured":"van der Hilst JC, Frenkel J. Hyperimmunoglobulin D syndrome in childhood. Curr Rheumatol Rep. 2010;12(2):101\u20137.","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"1617_CR2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-016-0091-7","volume":"14","author":"S Zhang","year":"2016","unstructured":"Zhang S. Natural history of mevalonate kinase deficiency: a literature review. Pediatr Rheumatol Online J. 2016;14(1):30.","journal-title":"Pediatr Rheumatol Online J."},{"key":"1617_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2147\/TACG.S93933","volume":"9","author":"LA Favier","year":"2016","unstructured":"Favier LA, Schulert GS. Mevalonate kinase deficiency: current perspectives. Appl Clin Genet. 2016;9:101\u201310.","journal-title":"Appl Clin Genet"},{"key":"1617_CR4","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1750-1172-1-13","volume":"1","author":"D Haas","year":"2006","unstructured":"Haas D, Hoffmann GF. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis. 2006;1:13 5.","journal-title":"Orphanet J Rare Dis"},{"key":"1617_CR5","unstructured":"Aygun D, Sahin S, Cokugras H, et al. Hyperimmunoglobulinaemia D syndrome: a rare cause of prolonged fever and treatment with anti-interleukin 1 agent. BMJ Case Rep. 2016:17, 2016."},{"issue":"3","key":"1617_CR6","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.clim.2012.09.011","volume":"147","author":"R Van der Burgh","year":"2013","unstructured":"Van der Burgh R, ter Haar NM, Boes ML, et al. Mevalonate kinase deficiency, a metabolic autoinflammatory disease. Clin Immunol. 2013;147(3):197\u2013206 6.","journal-title":"Clin Immunol"},{"issue":"1","key":"1617_CR7","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1111\/j.1651-2227.2010.01974.x","volume":"100","author":"M Korppi","year":"2011","unstructured":"Korppi M, Van Gijn ME, Antila K. Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report. Acta Paediatr. 2011;100(1):21\u20135 8.","journal-title":"Acta Paediatr"},{"issue":"6","key":"1617_CR8","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1007\/s00431-015-2505-9","volume":"174","author":"S Kostjukovits","year":"2015","unstructured":"Kostjukovits S, Kalliokoski L, Antila K, et al. Treatment of hyperimmunoglobulinemia D syndrome with biologics in children: review of the literature and Finnish experience. Eur J Pediatr. 2015;174(6):707\u201314.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"1617_CR9","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12969-016-0081-9","volume":"14","author":"S Peciuliene","year":"2016","unstructured":"Peciuliene S, Burnyte B, Gudaitiene R, et al. Perinatal manifestation of mevalonate kinase deficiency and efficacy of anakinra. Pediatr Rheumatol Online J. 2016;14(1):19.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"8","key":"1617_CR10","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1002\/art.40146","volume":"69","author":"JI Arostegui","year":"2017","unstructured":"Arostegui JI, Anton J, Calvo I, et al. Open-label, phase II study to assess the efficacy and safety of canakinumab treatment in active hyperimmunoglobulinemia D with periodic fever syndrome. Arthritis Rheumatol. 2017;69(8):1679\u201388.","journal-title":"Arthritis Rheumatol"},{"issue":"12","key":"1617_CR11","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1136\/ard.2011.149922","volume":"70","author":"EJ Bodar","year":"2011","unstructured":"Bodar EJ, Kuijk LM, Drenth JP, et al. On-demand anakinra treatment is effective in mevalonate kinase deficiency. Ann Rheum Dis. 2011;70(12):2155\u20138.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"1617_CR12","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1093\/rheumatology\/kes097","volume":"51","author":"C Galeotti","year":"2012","unstructured":"Galeotti C, Meinzer U, Quartier P, et al. Efficacy of interleukin-1-targeting drugs in mevalonate kinase deficiency. Rheumatology (Oxford). 2012;51(10):1855\u20139.","journal-title":"Rheumatology (Oxford)"},{"key":"1617_CR13","first-page":"795027","volume":"2013","author":"E Tsitsami","year":"2013","unstructured":"Tsitsami E, Papadopoulou C, Speletas M. A case of hyperimmunoglobulinemia D syndrome successfully treated with canakinumab. Case Rep Rheumatol. 2013;2013:795027 1\u20134.","journal-title":"Case Rep Rheumatol"},{"issue":"20","key":"1617_CR14","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","volume":"378","author":"F De Benedetti","year":"2018","unstructured":"De Benedetti F, Gattorno M, Anton J, et al. Canakinumab for the treatment of autoinflammatory recurrent fever syndromes. N Engl J Med. 2018;378(20):1908\u201319.","journal-title":"N Engl J Med"},{"key":"1617_CR15","first-page":"605","volume":"16","author":"M Di Gangi","year":"2014","unstructured":"Di Gangi M, Amato G, Converso G, et al. Long-term efficacy of adalimumab in hyper- immunoglobulin D and periodic fever syndrome. Isr Med Assoc J. 2014;16:605\u20137.","journal-title":"Isr Med Assoc J"},{"issue":"1","key":"1617_CR16","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/1750-1172-8-196","volume":"8","author":"L Cantarini","year":"2013","unstructured":"Cantarini L, Vitale A, Magnotti F, et al. Weekly oral alendronate in mevalonate kinase deficiency. Orphanet J Rare Dis. 2013;8(1):196.","journal-title":"Orphanet J Rare Dis."},{"issue":"4","key":"1617_CR17","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1007\/s00281-015-0492-6","volume":"37","author":"CM Mulders-Manders","year":"2015","unstructured":"Mulders-Manders CM, Simon A. Hyper-IgD syndrome\/mevalonate kinase deficiency: what is new? Semin Immunopathol. 2015;37(4):371\u20136.","journal-title":"Semin Immunopathol"},{"issue":"5","key":"1617_CR18","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.clpt.2004.01.012","volume":"75","author":"A Simon","year":"2004","unstructured":"Simon A, Drewe E, van der Meer JW, et al. Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther. 2004;75(5):476\u201383.","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"1617_CR19","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1111\/j.1600-6143.2011.03989.x","volume":"12","author":"S Chaudhury","year":"2012","unstructured":"Chaudhury S, Hormaza L, Mohammad S, et al. Liver transplantation followed by allogeneic hematopoietic stem cell transplantation for atypical mevalonic aciduria. Am J Transplant. 2012;12(6):1627\u201331.","journal-title":"Am J Transplant"},{"issue":"1","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"e211","DOI":"10.1542\/peds.2014-2553","volume":"135","author":"S Giardino","year":"2015","unstructured":"Giardino S, Lanino E, Morreale G, et al. Long-term outcome of a successful cord blood stem cell transplant in mevalonate kinase deficiency. Pediatrics. 2015;135(1):e211\u20135.","journal-title":"Pediatrics."},{"issue":"26","key":"1617_CR21","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.1056\/NEJMoa070715","volume":"356","author":"B Neven","year":"2007","unstructured":"Neven B, Valayannopoulos V, Quartier P, et al. Allogenic bone marrow transplantation in mevalonic aciduria. N Engl J Med. 2007;356(26):2700\u20133.","journal-title":"N Engl J Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12887-019-1617-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-019-1617-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T23:03:37Z","timestamp":1595113417000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-019-1617-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,20]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1186\/s12887-019-1617-1","relation":{},"ISSN":["1471-2431"],"issn-type":[{"type":"electronic","value":"1471-2431"}],"subject":[],"published":{"date-parts":[[2019,7,20]]},"assertion":[{"value":"18 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for publication was obtained from the mother of the patient in this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors TC, BB, HVM, MM, GMP declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"245"}}